Anita Katharina Wagner, PharmD, MPH, DrPH is Associate Professor in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She is a member of the Department’s Division of Health Policy and Insurance Research.
Dr. Wagner conducts applied research to inform policies and programs for improving medicines access, affordability, and use, particularly for populations in low and middle income countries (LMIC). She founded and leads the global Medicines and Insurance Coverage (MedIC) Initiative, a unique partnership between academics, health care delivery systems, health financing institutions, and international organizations, which aims to support LMIC system leaders and operational staff in their efforts to improve populations’ medicines situations, through evidence-informed policies and programs.
Dr. Wagner co-directs the Harvard Medical School Fellowship in Pharmaceutical Policy Research and directs global MedIC Courses in Pharmaceutical Policy Analysis
Dr. Wagner received her Master of Public Health degree in international health and Doctor of Public Health degree in epidemiology from the Harvard School of Public Health. She also holds a doctorate in clinical pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and a German master-equivalent degree in pharmacy. She is licensed to practice pharmacy in Germany and Massachusetts, USA.
Essential Medicines for Universal Health Coverage. Wirtz V, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Sun J, Luiza VL, Mbindyo RM, Moeller H, Moucheraud C, Pecoul B, Rago L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EFM, Wagner AK, Yadav P, Reich M. The Lancet. 2017Jan 28;389 (10067): 403-476.